BioSpace News Archive

A cardiac MRI is used to monitor or detect any heart-related abnormality or defect. Cardiac monitors use magnetic waves to produce a detailed picture of the heart.

Fact.MR - A Market Research and Competitive Intelligence Provider: The global nizatidine market is exhibiting a positive growth due to the increasing prevalence of gastric disorders such as Inflammatory Bowel Disease, constipation, hemorrhoids, stomach ulcers, etc.

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report January - June 2021. The presentation will be held in English.

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced The Lancet Infectious Diseases published results from the Phase I/II clinical trials of an inactivated COVID-19 vaccine developed by SINOVAC, also known as CoronaVac®, in healthy children and adolescents aged 3-17 in China.

NMD Pharma A/S, a biotech company leading in the development of novel therapeutics for neuromuscular disorders, announces that it has dosed the first myasthenia gravis patient in a combined Phase I/IIa clinical trial of NMD670, NMD Pharma’s lead program.

Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that it has adjourned its 2021 Annual Meeting of Stockholders due to a lack of quorum.

ArriVent Biopharma, Inc., industry leaders dedicated to accelerating the global development of innovative biopharmaceutical products, announced the launch of its company with up to $150 million in Series A financing and a potential best-in-class epidermal growth factor receptor tyrosine kinase inhibitor, furmonertinib, licensed from Shanghai-based, Allist Pharmaceuticals.

Qiagen’s Supervisory Board suffers from a lack of trust and confidence due to its history of ineffectiveness and governance concerns. This has created a credibility issue that is currently reflected in Qiagen’s steep valuation discount to peers and its own historic multiples, and negatively impacts the business.

Tiziana Life Sciences plc announces an interview with the Chairman of its’ Scientific Advisory Board and Professor of Neurology at Harvard Medical School, Dr Howard Weiner is to air on Bloomberg Markets with Matt Miller and Amanda Lang today at 1.50pm ET/6.50pm BST.

Imara Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, announced the election of Laura A. Williams, M.D., MPH to its Board of Directors.